1029 related articles for article (PubMed ID: 19521197)
1. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
2. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
[TBL] [Abstract][Full Text] [Related]
3. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
4. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of dialysis and ultrafiltrate from individuals with CKD, with or without diabetes, on platelet phosphatidylserine externalization.
Wang Y; Beck W; Deppisch R; Marshall SM; Hoenich NA; Thompson MG
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F220-8. PubMed ID: 17670899
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of nicotine infusion on platelets in nicotine users with normal and impaired renal function.
Whiss PA; Lundahl TH; Bengtsson T; Lindahl TL; Lunell E; Larsson R
Toxicol Appl Pharmacol; 2000 Mar; 163(2):95-104. PubMed ID: 10698667
[TBL] [Abstract][Full Text] [Related]
7. Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine.
Walkowiak B; Pawlowska Z; Michalak E; Cierniewski CS
Thromb Haemost; 1994 Feb; 71(2):164-8. PubMed ID: 8191392
[TBL] [Abstract][Full Text] [Related]
8. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
9. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
Bi SH; Cheng LT; Wang T
Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
[TBL] [Abstract][Full Text] [Related]
10. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
[TBL] [Abstract][Full Text] [Related]
12. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
Bonomini M; Sirolli V; Dottori S; Amoroso L; Di Liberato L; Arduini A
Nephrol Dial Transplant; 2007 Sep; 22(9):2623-9. PubMed ID: 17478491
[TBL] [Abstract][Full Text] [Related]
13. [Some parameters of platelet activation in patients with uremia before and after hemodialysis (HD)].
Dymicka-Piekarska V; Matowicka-Karna J; Mantur M; Kemona H; Piszka J
Przegl Lek; 2002; 59(12):980-3. PubMed ID: 12731371
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia.
Bonomini M; Dottori S; Amoroso L; Arduini A; Sirolli V
J Thromb Haemost; 2004 Aug; 2(8):1275-81. PubMed ID: 15304031
[TBL] [Abstract][Full Text] [Related]
15. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?
Sener A; Ozsavci D; Oba R; Demirel GY; Uras F; Yardimci KT
Clin Biochem; 2005 Dec; 38(12):1081-7. PubMed ID: 16253220
[TBL] [Abstract][Full Text] [Related]
16. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation.
Zilla P; Fasol R; Groscurth P; Klepetko W; Reichenspurner H; Wolner E
J Thorac Cardiovasc Surg; 1989 Mar; 97(3):379-88. PubMed ID: 2918735
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
18. Platelet function in sickle cell disease during steady state.
Triadou P; Fonty E; Ambrosio AS; Cottat MC; Girot R; Cornu P
Nouv Rev Fr Hematol (1978); 1990; 32(2):137-42. PubMed ID: 2143013
[TBL] [Abstract][Full Text] [Related]
19. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
Zuk E
Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
[TBL] [Abstract][Full Text] [Related]
20. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
